A randomized controlled trial of anterior colporraphy and PerigeeTM as surgical correction of symptomatic cystocele.

A randomized controlled trial of anterior colporraphy and PerigeeTM as surgical correction of symptomatic cystocele. - Anterior colporraphy versus Perigee

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30369

Enrollment

Registered

2007-01-03

Start date

2007-01-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cystocele prolapse of the anterior vaginal wall

Interventions

Anterior colporraphy or perigee

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who are candidate to undergo surgical correction of cystocele.

Exclusion criteria

Exclusion criteria: Patients who simultaneously have to undergo surgical correction of vault prolapse or rectocele are excluded. Patients who simultaneously have to undergo vaginal hysterectomy or stress-incontinence surgery are not excluded.

Design outcomes

Primary

Measure	Time frame
Disease specific quality of life.	—

Secondary

Measure	Time frame
1. Morbidity 2. Duration of catheter use 3. POP-Q score (Anatomical effect) 4. General quality of life 5. Performed surgical procedures in the first year after primary cystocele repair.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)